SCHEMBL7184540

SCHEMBL7184540

C=CC(C)(C)c1cc(C=CC(=O)c2ccc(OCOC(=O)C(C)(C)C)cc2)c(OCC)cc1OCOC(=O)C(C)(C)C

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 14/20 0.58
DPP4 P27487 3/20 0.50
IDH1 O75874 1/20 0.50
ABCB1 P08183 1/20 0.50
UGT1A1 P22309 1/20 0.50
ABCC1 P33527 1/20 0.50
PRMT6 Q96LA8 1/20 0.50
ABCG2 Q9UNQ0 1/20 0.50
CYP1A1 P04798 1/20 0.41
CYP1B1 Q16678 1/20 0.41
KDM4E B2RXH2 2/20 0.40
LMNA P02545 2/20 0.40
MAPT P10636 2/20 0.40
ALDH1A1 P00352 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7184531 1.00 PTPN1 (0.58) PTPN1DPP4IDH1ABCB1UGT1A1
SCHEMBL7188257 0.93 PTPN1 (0.56) PTPN1DPP4IDH1ABCB1UGT1A1
SCHEMBL7188272 0.93 PTPN1 (0.56) PTPN1DPP4IDH1ABCB1UGT1A1
SCHEMBL7188900 0.92 PTPN1 (0.70) PTPN1DPP4IDH1ABCB1UGT1A1
SCHEMBL7188892 0.92 PTPN1 (0.70) PTPN1DPP4IDH1ABCB1UGT1A1
SCHEMBL9274066 0.91 PTPN1 (0.49) PTPN1DPP4IDH1ABCB1UGT1A1
SCHEMBL7192137 0.91 DPP4 (0.48) PTPN1DPP4CYP1A1CYP1B1KDM4E
SCHEMBL7192131 0.91 DPP4 (0.48) PTPN1DPP4CYP1A1CYP1B1KDM4E
SCHEMBL7191178 0.90 DPP4 (0.49) PTPN1DPP4CYP1A1CYP1B1KDM4E
SCHEMBL7191175 0.90 DPP4 (0.49) PTPN1DPP4CYP1A1CYP1B1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed